Eris Lifesciences IPO subscribed by 9% till 2:45 PM
Eris Lifesciences IPO was subscribed by 9% as of 1445 hours on its last day of subscription.
The total issue size of 1,59,48,750 shares received 13,81,176 total bids and 5,75,424 bids at cut-off price.
The company’s existing shareholders will sell 28,875,000 equity shares. Private equity giant ChrysCapital’s investment arm Botticelli would sell its entire 16.25% stake or 22,344,000 shares, in Eris Lifesciences.
The company reported a constant rise in its revenue over the past five years. Its net revenue from operations for the year ended March 31, 2016, stood at around Rs 623.2 crore, witnessing a rise of around 11% on Y-o-Y basis.
Net profit for the year ended March 31, 2016, stood at approximately Rs 137.97 crore, witnessing a rise of 65% on Y-o-Y basis.
The total issue size of 1,59,48,750 shares received 13,81,176 total bids and 5,75,424 bids at cut-off price.
The company’s existing shareholders will sell 28,875,000 equity shares. Private equity giant ChrysCapital’s investment arm Botticelli would sell its entire 16.25% stake or 22,344,000 shares, in Eris Lifesciences.
The company reported a constant rise in its revenue over the past five years. Its net revenue from operations for the year ended March 31, 2016, stood at around Rs 623.2 crore, witnessing a rise of around 11% on Y-o-Y basis.
Net profit for the year ended March 31, 2016, stood at approximately Rs 137.97 crore, witnessing a rise of 65% on Y-o-Y basis.
Comments
Post a Comment